Skip to main content
Premium Trial:

Request an Annual Quote

Cheap and Fast

The US Food and Drug Administration has issued an Emergency Use Authorization for Abbott's BinaxNow COVID-19 Ag Card, an antigen test for SARS-CoV-2, as 360Dx reports.

According to the Verge, the test costs $5, takes 15 minutes, and is similar in design to a pregnancy test. It needs a nasal swab to be inserted into the card before a colored line appears indicating either the presence or absence of an infection. A study conducted by Abbott found the test to have a sensitivity of 97 percent and specificity of 98.5 percent in patients suspected of having COVID-19 within a week of symptom onset, 360Dx adds. 

At In the Pipeline, Derek Lowe notes that such a test could be helpful — if used properly. He points out the EUA is for testing of symptomatic people, which he says is appropriate. If the test were rolled out in a population with a low infection rate, there'd be too many false positives, but if used among people with a higher likelihood of having COVID-19, Lowe says the test could "do a huge amount of good."

"The availability of rapid testing for COVID-19 will help support overburdened laboratories, accelerate turnaround times and greatly expand access to people who need it," University of California, San Francisco's Charles Chiu says in a statement issued by Abbott.

The company is also launching a related phone app called Navica that will display patient's results and act as a sort of digital health pass, 360Dx adds.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.